Bluejay Diagnostics Updates Business and Corporate Progress for 2025

Tuesday, Jun 3, 2025 4:07 pm ET1min read

Bluejay Diagnostics, a medical diagnostics company, provided a mid-year business update highlighting recent developments in its SYMON clinical program, regulatory pathway, manufacturing progress, and financial results. The company initiated the SYMON-II clinical study and plans to submit a 510(k) regulatory application to the FDA in Q4 2027. It also raised $3.8 million in April 2025 and is seeking further financing to raise at least $30 million.

Bluejay Diagnostics Updates Business and Corporate Progress for 2025

Comments



Add a public comment...
No comments

No comments yet